---
$id: https://graph.org.ai/products/commodity/51271804
$type: Product
source: UNSPSC
code: "51271804"
title: "Quatacaine"
class: "51271800"
classTitle: "Anaesthetic amines"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Quatacaine

**UNSPSC Code**: 51271804
**Class**: [Anaesthetic amines](Anaesthetic amines.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C14H22N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49BR7256ZY, chemically known as propanamide, 2-methyl-n-(2-methylphenyl)-2-(propylamino)- but generally known as quatacaine, which bears US NIH Compound Identifier 65685. European Medicines Agency schedules Quatacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10187MIG. The term QUATACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). QUATACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quatacaine under HS 29242995 and SITC 51479. As of Q4 2014, QUATACAINE remains the US FDA Preferred Term for this commodity. Quatacaine bears US NLM identifiers UMLS ID C0072824 and NCI Concept Code C72164. SMILES: O=C(NC1C(CCCC1)C)C(NCCC)(C)C.

